PublishedMay 26, 2025

Federal Judges Admit Lack of Technical Expertise, Making the Case for an Accessible PTAB

At the American Bar Association’s Intellectual Property Law Section spring conference at the start of May, a group of federal judges overseeing complex patent lawsuits admitted they are not experts in the specialized technological fields underlying patent litigation. According to reporting from Bloomberg Law, Senior Judge William Bryson of the Court of Appeals for the Federal Circuit candidly stated, “People like me are experts in no fields,” while Judge Kara Stoll added, “It’s been a long time since I got my degree,” emphasizing, “It’s imperative that you teach us.”

This admission, while unsurprising, is notable in light of ongoing debates around the utility of the Patent Trial and Appeal Board (PTAB). With district court judges managing expansive dockets—“350 to 400 cases on our docket at any given time,” according to Judge Gregory B. Williams of the District of Delaware—it’s unreasonable to expect them to master the wide range of technological fields involved in patent cases. From biotechnology and semiconductors to software and telecommunications patents, the sheer volume of unique inventorship issues, prior art determinations, and technical jargon makes it impractical for any single district court judge to become an expert while also handling hundreds of other cases across various legal areas.

In addition to being more efficient and less expensive than traditional litigation, expertise is another PTAB asset. PTAB judges are experts in these fields—they don’t need to be taught. As noted by leading IP firm Fish & Richardson, “In contrast to federal district court judges, APJs are more likely to possess substantive experience in patent law as well as the technical expertise of the patent under review.” 

It is partly because of this expertise that Congress, when passing the America Invents Act, expected federal judges to stay proceedings if related patent validity challenges were playing out at the PTAB. Instead, USPTO leadership has actively committed to directing questions of patent validity away from the agency’s technically-trained judges and into federal courts where cases are overseen by judges who are, by their own account, not experts. 

One might assume that the USPTO would be invested in promoting itself as the arbiter of disputes it is uniquely qualified to resolve. Of late, the opposite has been true. 

Josh Landau

Patent Counsel, CCIA

Joshua Landau is the Patent Counsel at the Computer & Communications Industry Association (CCIA), where he represents and advises the association regarding patent issues.  Mr. Landau joined CCIA from WilmerHale in 2017, where he represented clients in patent litigation, counseling, and prosecution, including trials in both district courts and before the PTAB.

Prior to his time at WilmerHale, Mr. Landau was a Legal Fellow on Senator Al Franken’s Judiciary staff, focusing on privacy and technology issues.  Mr. Landau received his J.D. from Georgetown University Law Center and his B.S.E.E. from the University of Michigan.  Before law school, he spent several years as an automotive engineer, during which time he co-invented technology leading to U.S. Patent No. 6,934,140.

Follow @PatentJosh on Twitter.

More Posts

Tuesday Markup of Litigation Funding Legislation

Although John Squires is busy destroying the PTAB—as of last week, he has now gone 0 for 34 on allowing institution of IPR petitions he reviews—the story in Congress is more positive. Tomorrow, t...

Step 1: Destroy IPR.  Step 2: ???  Step 3: Profit.

Last week, the USPTO issued a Notice of Proposed Rulemaking (NPRM) containing major changes to the institution process for inter partes review.  Combined with other changes made by the USPTO, inc...

Capable of Repetition, But Avoiding Review—USPTO New Regulation Not Reviewed By OIRA

The USPTO has put out a new NPRM, attempting to lock in place rules that were created without going through rulemaking in the prior Trump administration. While I have a lot to say about the substance...

Subscribe to Patent Progress

No spam. Unsubscribe anytime.